This inventor holds 1 USPTO granted patent. Top assignee: Metabolic Pharmaceuticals Limited. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Woel-Jia Jiang: Innovator in Obesity Treatment
Introduction
Woel-Jia Jiang is a notable inventor based in Clayton, Australia. He has made significant contributions to the field of obesity treatment through his innovative research and development.
Latest Patents
Jiang holds a patent for a method aimed at treating obesity in animals, including humans. This method involves administering an effective amount of a peptide that comprises an analogue of the carboxyl-terminal sequence of growth hormone. Specifically, it focuses on an analogue of the carboxyl-terminal sequence of human growth hormone containing amino acid residues 177-191. Additionally, a pharmaceutical composition for use in the treatment of obesity is disclosed in his patent.
Career Highlights
Woel-Jia Jiang is associated with Metabolic Pharmaceuticals Limited, where he continues to work on innovative solutions for metabolic disorders. His research has the potential to impact the lives of many individuals struggling with obesity.
Collaborations
Jiang collaborates with Frank Man-Woon Ng, contributing to advancements in their field.
Conclusion
Woel-Jia Jiang's work in obesity treatment showcases his dedication to innovation and improving health outcomes. His contributions are paving the way for new therapeutic approaches in the fight against obesity.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile